Justin Levisay to Risk Assessment
This is a "connection" page, showing publications Justin Levisay has written about Risk Assessment.
Connection Strength
0.078
-
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients. Circ Cardiovasc Interv. 2024 Aug; 17(8):e013782.
Score: 0.031
-
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovasc Drugs Ther. 2024 Jun; 38(3):447-457.
Score: 0.028
-
Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv. 2018 09 01; 92(3):E185-E196.
Score: 0.019